Cardinal Strategic Wealth Guidance Pfizer Inc Transaction History

Cardinal Strategic Wealth Guidance

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $81,133 - $105,383	-3,105 Reduced 25.38%	9,127 $262,000
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $1,411 - $1,650	-44 Reduced 0.36%	12,232 $405,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $28,895 - $33,432	-800 Reduced 6.12%	12,276 $450,000
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $100,680 - $131,071	-2,556 Reduced 16.35%	13,076 $533,000
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $4,634 - $6,049	-111 Reduced 0.71%	15,632 $0
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $8,142 - $9,654	-175 Reduced 1.1%	15,743 $821,000
Q1 2022 Apr 26, 2022	SELL	$45.75 - $56.69 $8,235 - $10,204	-180 Reduced 1.12%	15,918 $826,000
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $23,157 - $29,747	-590 Reduced 3.54%	16,098 $692,000
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $25,136 - $28,476	-700 Reduced 4.03%	16,688 $653,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $54,555 - $61,527	-1,629 Reduced 8.57%	17,388 $630,000
Q4 2020 Jan 29, 2021	SELL	$33.47 - $42.56 $33,871 - $43,070	-1,012 Reduced 5.05%	19,017 $700,000
Q3 2020 Oct 21, 2020	SELL	$31.75 - $37.25 $32,861 - $38,553	-1,035 Reduced 4.91%	20,029 $733,000
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $34,999 - $42,459	-1,162 Reduced 5.23%	21,064 $689,000
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $17,974 - $25,682	-665 Reduced 2.91%	22,226 $726,000
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $753,571 - $855,207	22,891 New	22,891 $896,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cardinal Strategic Wealth Guidance, based on Form 13F filings with the SEC.

Stay updated on Cardinal Strategic Wealth Guidance with notifications on news.